Drug Profile
FP 0153
Alternative Names: FP0153Latest Information Update: 06 Jun 2007
Price :
$50
*
At a glance
- Originator Faust Pharmaceuticals
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Migraine; Parkinson's disease
Most Recent Events
- 06 Jun 2007 Discontinued - Preclinical for Migraine in France (unspecified route)
- 06 Jun 2007 Discontinued - Preclinical for Parkinson's disease in France (unspecified route)
- 01 Dec 2005 Preclinical trials in Parkinson's disease in France (unspecified route)